Overview

  • Product namePNU 282987
  • Description
    Selective α7 nAChR agonist
  • Biological descriptionSelective α7nAChR agonist. Negligible activity at α1β1γδ and α3β4 receptors. High affinity for rat α7nACh receptors (Ki = 26 nM). Functional antagonist at 5-HT3 receptors (IC50 = 4541 nM).
  • Purity> 99%

Properties

    References for PNU 282987 (ab120558)

    This product has been referenced in:
    • Vicens P  et al. Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice. Behav Brain Res 216:341-8 (2011). Read more (PubMed: 20728474) »
    • Hajós M  et al. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther 312:1213-22 (2005). Read more (PubMed: 15523001) »
    • Bodnar AL  et al. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. J Med Chem 48:905-8 (2005). Read more (PubMed: 15715459) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120558.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"